Category : Metabolic Conditions

Non-alcoholic fatty liver disease (NAFLD) is the main cause of chronic liver disease in developed countries. NAFLD often shares symptoms with other metabolic disorders such as type 2 diabetes and obesity. Recently, our gut microbiota has been revealed as a contributor to fatty liver disease development in both rodent models and NAFLD patients. However, the question of whether gut microbes…

GMFH Editing Team
GMFH Editing Team

Non-alcoholic fatty liver disease (NAFLD) is the main cause of chronic liver disease in developed countries. NAFLD often shares symptoms with other metabolic disorders such as type 2 diabetes and obesity. Recently, our gut microbiota has been revealed as a contributor to fatty liver disease development in both rodent models and NAFLD patients. However, the question of whether gut microbes…

GMFH Editing Team
GMFH Editing Team

Obesity and type 2 diabetes (T2D) have been associated with alterations in the gut microbiome. Given that both conditions are commonly manifested together and that ruling out the impact of external confounding factors in microbiome variation is a challenge, scientists struggle with teasing out gut microbiome hallmarks that uniquely characterize each of the two conditions. Louise Thingholm from Kiel University…

GMFH Editing Team
GMFH Editing Team

Obesity and type 2 diabetes (T2D) have been associated with alterations in the gut microbiome. Given that both conditions are commonly manifested together and that ruling out the impact of external confounding factors in microbiome variation is a challenge, scientists struggle with teasing out gut microbiome hallmarks that uniquely characterize each of the two conditions. Louise Thingholm from Kiel University…

GMFH Editing Team
GMFH Editing Team

Nonsteroidal anti-inflammatory drugs (NSAIDs) are among one of the most frequently prescribed drugs that often cause mucosal lesions in the gastrointestinal tract. However, there are few effective agents for treating small intestinal lesions. As such, developing effective treatments for managing NSAID-induced small intestinal lesions is a priority. In mice and humans, the gut microbiota, bile salt acids and the enterohepatic…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Nonsteroidal anti-inflammatory drugs (NSAIDs) are among one of the most frequently prescribed drugs that often cause mucosal lesions in the gastrointestinal tract. However, there are few effective agents for treating small intestinal lesions. As such, developing effective treatments for managing NSAID-induced small intestinal lesions is a priority. In mice and humans, the gut microbiota, bile salt acids and the enterohepatic…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Imbalances in gut microbiota composition have recently been reported in people suffering from metabolic syndrome (MetS). This has led the scientific community to explore the gut microbiota's contribution to the benefits of lifestyle interventions for improving the hallmarks of MetS and related manifestations. Previous observational findings have shown that consuming fermented dairy products is related to a healthier lifestyle and…

GMFH Editing Team
GMFH Editing Team

Imbalances in gut microbiota composition have recently been reported in people suffering from metabolic syndrome (MetS). This has led the scientific community to explore the gut microbiota's contribution to the benefits of lifestyle interventions for improving the hallmarks of MetS and related manifestations. Previous observational findings have shown that consuming fermented dairy products is related to a healthier lifestyle and…

GMFH Editing Team
GMFH Editing Team

Breast milk has been reported as a multifunctional fluid, which includes human milk oligosaccharides (HMOs) that may influence the development of the gut microbiota and the training of a newborn baby's immune system. A recent pilot study led by Dr. Mireille van Poppel and colleagues from the University of Graz and BioTechMed-Graz in Austria has revealed that during pregnancy, HMOs…

GMFH Editing Team
GMFH Editing Team

Breast milk has been reported as a multifunctional fluid, which includes human milk oligosaccharides (HMOs) that may influence the development of the gut microbiota and the training of a newborn baby's immune system. A recent pilot study led by Dr. Mireille van Poppel and colleagues from the University of Graz and BioTechMed-Graz in Austria has revealed that during pregnancy, HMOs…

GMFH Editing Team
GMFH Editing Team

The second phase of the 10-year National Institutes of Health-funded Human Microbiome Project, the Integrative Human Microbiome Project, has recently been completed and provides a useful repository of microbiome-related data, tools and protocols for the research community. The two studies featured in this post have characterized host-microbiome interactions through longitudinal sampling in inflammatory bowel diseases (IBDs) and prediabetes. Although some…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

The second phase of the 10-year National Institutes of Health-funded Human Microbiome Project, the Integrative Human Microbiome Project, has recently been completed and provides a useful repository of microbiome-related data, tools and protocols for the research community. The two studies featured in this post have characterized host-microbiome interactions through longitudinal sampling in inflammatory bowel diseases (IBDs) and prediabetes. Although some…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Metabolic syndrome (MetS) is a common condition worldwide that has been related not only to biochemical abnormalities and inflammation, but also to imbalances in the gut microbiota. Researchers from the National Institute of Medical Sciences and Nutrition Salvador Zubirán and the National Autonomous University of Mexico in Mexico City have found that the gut microbiota may explain the benefits of…

GMFH Editing Team
GMFH Editing Team

Metabolic syndrome (MetS) is a common condition worldwide that has been related not only to biochemical abnormalities and inflammation, but also to imbalances in the gut microbiota. Researchers from the National Institute of Medical Sciences and Nutrition Salvador Zubirán and the National Autonomous University of Mexico in Mexico City have found that the gut microbiota may explain the benefits of…

GMFH Editing Team
GMFH Editing Team

The gut microbiota has become a new player in the onset and development of metabolic syndrome and its associated pathologies. One gut bacterium that has been positively associated with leanness in mice and humans is Akkermansia muciniphila, which is naturally present in the gut microbiota of healthy people. In 2017, our research team at UCLouvain (Belgium) found that a pasteurized…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

The gut microbiota has become a new player in the onset and development of metabolic syndrome and its associated pathologies. One gut bacterium that has been positively associated with leanness in mice and humans is Akkermansia muciniphila, which is naturally present in the gut microbiota of healthy people. In 2017, our research team at UCLouvain (Belgium) found that a pasteurized…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

Over 350 physicians, dietitians, nutritionists, advanced practice providers and researchers from 49 countries gathered in Miami (USA), on March 23-24, for the 8th edition of the Gut Microbiota for Health World Summit 2019, where world-renowned experts in the field discussed the latest evidence on the interaction between diet, nutrition and the gut microbiome. With Gail Hecht and Francisco Guarner as…

GMFH Editing Team
GMFH Editing Team

Over 350 physicians, dietitians, nutritionists, advanced practice providers and researchers from 49 countries gathered in Miami (USA), on March 23-24, for the 8th edition of the Gut Microbiota for Health World Summit 2019, where world-renowned experts in the field discussed the latest evidence on the interaction between diet, nutrition and the gut microbiome. With Gail Hecht and Francisco Guarner as…

GMFH Editing Team
GMFH Editing Team

Genes from the gut microbiota encode for a wide range of metabolic activities that allow commensal microbes to ferment dietary fibers and prebiotics into metabolites that include short chain fatty acids (SCFAs). Of these, propionate has been shown to trigger the secretion of gut peptides that take part in regulating appetite and glucose metabolism and reducing inflammation. Although colonic propionate…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Genes from the gut microbiota encode for a wide range of metabolic activities that allow commensal microbes to ferment dietary fibers and prebiotics into metabolites that include short chain fatty acids (SCFAs). Of these, propionate has been shown to trigger the secretion of gut peptides that take part in regulating appetite and glucose metabolism and reducing inflammation. Although colonic propionate…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados